Connection

M ATASSI to Peptide Fragments

This is a "connection" page, showing publications M ATASSI has written about Peptide Fragments.
Connection Strength

4.758
  1. Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. J Neuroimmunol. 2016 11 15; 300:36-46.
    View in: PubMed
    Score: 0.383
  2. Reduction of established antibody responses against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol peptide conjugates. J Neuroimmunol. 2014 Jul 15; 272(1-2):29-34.
    View in: PubMed
    Score: 0.325
  3. Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains. Immunobiology. 2012 Jan; 217(1):1-7.
    View in: PubMed
    Score: 0.270
  4. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 2012 Jan; 217(1):17-27.
    View in: PubMed
    Score: 0.269
  5. Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates. Immunol Lett. 2011 Jun 30; 137(1-2):46-52.
    View in: PubMed
    Score: 0.260
  6. Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology. 2011 Jul; 216(7):782-92.
    View in: PubMed
    Score: 0.257
  7. Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin. Mol Immunol. 2008 Feb; 45(4):910-24.
    View in: PubMed
    Score: 0.205
  8. Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90.
    View in: PubMed
    Score: 0.141
  9. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Crit Rev Immunol. 2001; 21(1-3):1-27.
    View in: PubMed
    Score: 0.129
  10. Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. J Neuroimmunol. 2000 Jun 26; 105(2):131-44.
    View in: PubMed
    Score: 0.124
  11. Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of Myasthenia gravis? Hum Immunol. 2000 Mar; 61(3):255-65.
    View in: PubMed
    Score: 0.121
  12. Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc. Immunol Lett. 1998 Jan; 60(1):7-12.
    View in: PubMed
    Score: 0.105
  13. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Autoimmunity. 2017 Aug; 50(5):293-305.
    View in: PubMed
    Score: 0.100
  14. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor. J Immunol. 1996 Oct 01; 157(7):3192-9.
    View in: PubMed
    Score: 0.096
  15. Effects of membrane properties on the binding activities of the HN and HC heavy-chain domains of botulinum neurotoxin A. Biochim Biophys Acta. 2016 12; 1864(12):1678-1685.
    View in: PubMed
    Score: 0.095
  16. Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin. Sci Rep. 2015 Oct 28; 5:15776.
    View in: PubMed
    Score: 0.090
  17. Mapping of the polypeptide chain organization of the main extracellular domain of the alpha-subunit in membrane-bound acetylcholine receptor by antipeptide antibodies spanning the entire domain. Adv Exp Med Biol. 1994; 347:221-8.
    View in: PubMed
    Score: 0.079
  18. Mapping the extracellular topography of the alpha-chain in free and in membrane-bound acetylcholine receptor by antibodies against overlapping peptides spanning the entire extracellular parts of the chain. J Protein Chem. 1994 Jan; 13(1):37-47.
    View in: PubMed
    Score: 0.079
  19. Biological activities of rat antisera raised against synthetic peptides of human thyrotropin receptor. Endocr J. 1993 Oct; 40(5):607-12.
    View in: PubMed
    Score: 0.078
  20. Amino acid substitutions outside a preselected antigenic region in hemoglobin affect the binding to monoclonal antibodies obtained by immunization with the synthetic region. J Protein Chem. 1993 Aug; 12(4):403-12.
    View in: PubMed
    Score: 0.077
  21. Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease. Mol Cell Endocrinol. 1993 Mar; 92(1):77-82.
    View in: PubMed
    Score: 0.075
  22. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 113-120 (antigenic site 4) of myoglobin. J Protein Chem. 1992 Dec; 11(6):677-86.
    View in: PubMed
    Score: 0.074
  23. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 145-151 (antigenic site 5) of myoglobin. J Protein Chem. 1992 Dec; 11(6):687-98.
    View in: PubMed
    Score: 0.074
  24. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 94-100 (antigenic site 3) of myoglobin. J Protein Chem. 1992 Oct; 11(5):433-44.
    View in: PubMed
    Score: 0.073
  25. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 15-22 (antigenic site 1) of myoglobin. J Protein Chem. 1992 Oct; 11(5):445-54.
    View in: PubMed
    Score: 0.073
  26. Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 56-62 (antigenic site 2) of myoglobin. J Protein Chem. 1992 Oct; 11(5):455-65.
    View in: PubMed
    Score: 0.073
  27. HLA-DR peptide inhibits HIV-induced syncytia. Immunol Lett. 1990 May; 24(2):127-31.
    View in: PubMed
    Score: 0.061
  28. Generation of species-specific antihemoglobin antibodies by immunization with synthetic peptides of human hemoglobin. J Protein Chem. 1989 Dec; 8(6):767-78.
    View in: PubMed
    Score: 0.060
  29. Comparison of peptide-coating conditions in solid phase plate assays for detection of anti-peptide antibodies. Immunol Invest. 1989 Aug; 18(7):841-51.
    View in: PubMed
    Score: 0.058
  30. Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action. Crit Rev Immunol. 2007; 27(4):319-41.
    View in: PubMed
    Score: 0.049
  31. T-cell dependency of the antibody response to free small synthetic peptides of a protein: demonstration with an antigenic site of myoglobin. Immunol Invest. 1985 Feb; 14(1):1-5.
    View in: PubMed
    Score: 0.043
  32. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity. Hum Immunol. 2005 Jan; 66(1):32-42.
    View in: PubMed
    Score: 0.042
  33. Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain. Protein J. 2004 Nov; 23(8):539-52.
    View in: PubMed
    Score: 0.042
  34. Basic immunological aspects of botulinum toxin therapy. Mov Disord. 2004 Mar; 19 Suppl 8:S68-84.
    View in: PubMed
    Score: 0.040
  35. Antibodies to sperm-whale myoglobin evoked by free synthetic peptides of an antigenic site. Immunol Commun. 1982; 11(1):9-16.
    View in: PubMed
    Score: 0.034
  36. B-cell activation in vitro by helper T cells specific to a protein region that is recognized both by T cells and by antibodies. Immunol Invest. 1998 May; 27(3):121-34.
    View in: PubMed
    Score: 0.027
  37. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products. Autoimmunity. 1998; 27(2):79-90.
    View in: PubMed
    Score: 0.026
  38. Immune recognition of botulinum neurotoxin type A: regions recognized by T cells and antibodies against the protective H(C) fragment (residues 855-1296) of the toxin. Mol Immunol. 1997 Oct; 34(14):1031-40.
    View in: PubMed
    Score: 0.026
  39. Intersite helper function of T cells specific for a protein epitope that is not recognized by antibodies. Immunol Invest. 1997 Jun; 26(4):473-89.
    View in: PubMed
    Score: 0.025
  40. Localization of the regions on the C-terminal domain of the heavy chain of botulinum A recognized by T lymphocytes and by antibodies after immunization of mice with pentavalent toxoid. Immunol Invest. 1997 Jun; 26(4):491-504.
    View in: PubMed
    Score: 0.025
  41. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species. J Protein Chem. 1996 Oct; 15(7):691-700.
    View in: PubMed
    Score: 0.024
  42. Antibody and T-cell recognition of alpha-bungarotoxin and its synthetic loop-peptides. Mol Immunol. 1995 Aug; 32(12):919-29.
    View in: PubMed
    Score: 0.022
  43. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162. J Immunol. 1995 May 15; 154(10):5245-54.
    View in: PubMed
    Score: 0.022
  44. Molecular recognition of acetylcholine receptor. Recognition by alpha-neurotoxins and by immune and autoimmune responses and manipulation of the responses. Adv Neuroimmunol. 1994; 4(4):403-32.
    View in: PubMed
    Score: 0.020
  45. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance. Adv Exp Med Biol. 1994; 347:65-75.
    View in: PubMed
    Score: 0.020
  46. Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
    View in: PubMed
    Score: 0.018
  47. HIV envelope protein is recognized as an alloantigen by human DR-specific alloreactive T cells. Hum Immunol. 1992 May; 34(1):31-8.
    View in: PubMed
    Score: 0.018
  48. Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem. 1990 Dec; 9(6):735-42.
    View in: PubMed
    Score: 0.016
  49. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit. Eur J Immunol. 1990 Dec; 20(12):2563-9.
    View in: PubMed
    Score: 0.016
  50. T cells specific for alpha-beta interface regions of hemoglobin recognize the isolated subunit but not the tetramer and indicate presentation without processing. Proc Natl Acad Sci U S A. 1989 Sep; 86(17):6729-33.
    View in: PubMed
    Score: 0.015
  51. Cytotoxic T lymphocyte recognition sites on influenza virus hemagglutinin. Immunol Lett. 1988 Sep; 19(1):49-53.
    View in: PubMed
    Score: 0.014
  52. Recognition of inter-transmembrane regions of acetylcholine receptor alpha subunit by antibodies, T cells and neurotoxins. Implications for membrane-subunit organization. FEBS Lett. 1988 Feb 15; 228(2):295-300.
    View in: PubMed
    Score: 0.013
  53. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc Natl Acad Sci U S A. 1985 Dec; 82(24):8805-9.
    View in: PubMed
    Score: 0.011
  54. Antigenicity of synthetic peptides 159-169 and 151-169 of Torpedo acetylcholine receptor alpha chain. Biochem J. 1985 Oct 01; 231(1):245-6.
    View in: PubMed
    Score: 0.011
  55. Antigen presentation of myoglobin: profiles of T cell proliferative responses following priming with synthetic overlapping peptides encompassing the entire molecule. Eur J Immunol. 1985 Sep; 15(9):917-22.
    View in: PubMed
    Score: 0.011
  56. Localization of the continuous allergenic sites of ragweed allergen Ra3 by a comprehensive synthetic strategy. FEBS Lett. 1985 Aug 19; 188(1):96-100.
    View in: PubMed
    Score: 0.011
  57. Perspectives of the immunology of proteins. Adv Exp Med Biol. 1985; 185:1-25.
    View in: PubMed
    Score: 0.011
  58. T cell recognition of lysozyme. IV. Localization and genetic control of the continuous T cell recognition sites by synthetic overlapping peptides representing the entire protein chain. J Immunogenet. 1984 Oct-Dec; 11(5-6):327-37.
    View in: PubMed
    Score: 0.010
  59. T cell recognition of myoglobin. Localization of the sites stimulating T cell proliferative responses by synthetic overlapping peptides encompassing the entire molecule. J Immunogenet. 1984 Oct-Dec; 11(5-6):339-53.
    View in: PubMed
    Score: 0.010
  60. T-cell recognition of lysozyme. I. Localization of regions stimulating T-cell proliferative response by synthetic overlapping peptides encompassing the entire molecule. Exp Clin Immunogenet. 1984; 1(2):99-111.
    View in: PubMed
    Score: 0.010
  61. Dissection of the molecular parameters for T-cell recognition of a myoglobin antigenic site. Adv Exp Med Biol. 1982; 150:73-93.
    View in: PubMed
    Score: 0.009
  62. Genetic control and intersite influences on the immune response to sperm whale myoglobin. Adv Exp Med Biol. 1982; 150:97-125.
    View in: PubMed
    Score: 0.009
  63. Immune recognition of serum albumin--XII. Evidence for time-dependent immunochemical cross-reactivity of subdomains 3, 6 and 9 of bovine serum albumin by quantitative immunoadsorbent titration studies. Mol Immunol. 1981 Jun; 18(6):553-60.
    View in: PubMed
    Score: 0.008
  64. A novel and comprehensive synthetic approach for the elucidation of protein antigenic structures. Determination of the full antigenic profile of the alpha-chain of human haemoglobin. Biochem J. 1980 Oct 01; 191(1):261-4.
    View in: PubMed
    Score: 0.008
  65. Antibody combining sites can be mimicked synthetically. Surface-simulation synthesis of the phosphorylcholine-combining site of myeloma protein M-603. Biochem J. 1980 Jun 01; 187(3):661-6.
    View in: PubMed
    Score: 0.008
  66. The antigenic structure of myoglobin and initial consequences of its precise determination. CRC Crit Rev Biochem. 1979; 6(4):337-69.
    View in: PubMed
    Score: 0.007
  67. Determination of the entire antigenic structure of native lysozyme by surface-simulation synthesis, a novel concept in molecular recognition. CRC Crit Rev Biochem. 1979; 6(4):371-400.
    View in: PubMed
    Score: 0.007
  68. Precise determination of the entire antigenic structure of lysozyme: molecular features of protein antigenic structures and potential of "surface-simulation" synthesis--a powerful new concept for protein binding sites. Immunochemistry. 1978 Dec; 15(12):909-36.
    View in: PubMed
    Score: 0.007
  69. Boundary refinement of the lysozyme antigenic site around the disulphide bond 6-127 (site 1) by 'surface-simulation' synthesis. Biochem J. 1978 May 01; 171(2):419-27.
    View in: PubMed
    Score: 0.007
  70. The precise and entire antigenic structure of lysozyme: implications of surface-simulation synthesis and the molecular features of protein antigenic sites. Adv Exp Med Biol. 1978; 98:41-99.
    View in: PubMed
    Score: 0.007
  71. Can an antibody-combining site be mimicked synthetically? The possible surface simulation synthesis of two antibody-combining sites complementary to two antigenic sites of lysozyme. J Biol Chem. 1977 Dec 25; 252(24):8784-7.
    View in: PubMed
    Score: 0.007
  72. Enzymic and immunochemical properties of lysozyme. XIX. Definition of the direction and conformational restrictions of the antigenic site around the disulfide bonds 64-80 and 76-94 (site 2) by 'surface-simulation' synthesis. Biochim Biophys Acta. 1977 Dec 20; 495(2):354-68.
    View in: PubMed
    Score: 0.007
  73. Chemical strategy for studying the antigenic structures of disulfide-containing proteins: hen egg-white lysozyme as a model. Adv Exp Med Biol. 1977; 86A:89-137.
    View in: PubMed
    Score: 0.006
  74. A fragment comprising the last third of bovine serum albumin which accounts for almost all the antigenic reactivity of the native protein. J Biol Chem. 1976 Aug 10; 251(15):4616-21.
    View in: PubMed
    Score: 0.006
  75. Immunochemistry of serum albumin--II. Isolation and characterization of a fragment from the first third of bovine serum albumin carrying almost all the antigenic reactivity of the protein. Immunochemistry. 1976 Jun; 13(6):547-55.
    View in: PubMed
    Score: 0.006
  76. Enzymic and immunochemical properties of lysozyme. XVI. A novel synthetic approach to an antigenic reactive site by direct linkage of the relevant conformationally adjacent residues constituting the site. Biochim Biophys Acta. 1976 Apr 14; 427(2):745-51.
    View in: PubMed
    Score: 0.006
  77. Conformation, enzymic activity, and immunochemistry of a lysozyme derivative modified at tryptophan 123 by reaction with 2,3-dioxo-5-indolinesulfonic acid. J Biol Chem. 1976 Mar 25; 251(6):1653-8.
    View in: PubMed
    Score: 0.006
  78. Enzymic and immunochemical properties of lysozyme. XIII. Accurate delineation of the reactive site around the disulfide 6-127 by immunochemical study of beta-propiolactone lysozyme derivative and of synthetic disulfide peptides. Biochim Biophys Acta. 1976 Feb 20; 420(2):358-75.
    View in: PubMed
    Score: 0.006
  79. Enzymic and immunochemical properties of lysozyme. XI. Conformation and immunochemistry of the two-disulfide peptide and the tryptophan and lysine residues in its antigenic reactivity. Biochim Biophys Acta. 1975 Oct 20; 405(2):464-74.
    View in: PubMed
    Score: 0.006
  80. Immunochemistry of sperm-whale myoglobin--XXII. Accurate delineation of the single reactive region in sequence 103-120 by immunochemical studies of synthetic peptides: the complete antigenic structure of the protein. Immunochemistry. 1975 Sep; 12(9):735-40.
    View in: PubMed
    Score: 0.006
  81. Antigenic structure of myoglobin: the complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins. Immunochemistry. 1975 May; 12(5):423-38.
    View in: PubMed
    Score: 0.005
  82. Immunochemistry of sperm-whale myoglobin--XX. Accurate delineation of the single reactive region in sequence 80-103 by immunochemical studies of synthetic peptides. Immunochemistry. 1975 Apr; 12(4):285-90.
    View in: PubMed
    Score: 0.005
  83. Conformational studies on modified proteins and peptides. IX. Conformation and immunochemistry of hemoglobin reduced at some carboxyl groups by diborane. Biochim Biophys Acta. 1975 Jan 30; 379(1):1-12.
    View in: PubMed
    Score: 0.005
  84. Immunochemistry of sperm-whale myoglobin. XIX. Accurate delineation of the single reactive region in sequence 54-85 by immunochemical study of synthetic peptides. Biochim Biophys Acta. 1974 Mar 14; 342(1):21-9.
    View in: PubMed
    Score: 0.005
  85. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin Immunol Immunopathol. 1993 Mar; 66(3):230-8.
    View in: PubMed
    Score: 0.005
  86. Binding of thyroid hormones to human hemoglobin and localization of the binding site. J Protein Chem. 1990 Dec; 9(6):743-50.
    View in: PubMed
    Score: 0.004
  87. T cell response to myoglobin: a comparison of T cell clones in high-responder and low-responder mice. Eur J Immunol. 1988 Sep; 18(9):1329-35.
    View in: PubMed
    Score: 0.003
  88. Myoglobin-reactive T cell clones. Adv Exp Med Biol. 1982; 150:159-82.
    View in: PubMed
    Score: 0.002
  89. Peptides with strong immunochemical inhibitory activity from bovine serum albumin. Application of a novel approach. Biochim Biophys Acta. 1974 Apr 11; 342(2):389-95.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.